Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients

NCT00004999 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lamivudine/Zidovudine
DRUG: Capravirine
DRUG: Nelfinavir mesylate

Sponsor

Agouron Pharmaceuticals